Literature DB >> 544528

Metastasis of human tumors in athymic nude mice.

F E Sharkey, J Fogh.   

Abstract

The incidence of metastasis of xenogeneic tumors transplanted to nude mice is controversial. We studied 106 malignant human tumor lines in a total of 1,045 nude mice, and observed metastasis in only 14 instances (1.3%), involving 11 different tumor lines. Three of the lines showed repeated metastasis. Breast tumor lines metastasized with significantly greater frequency than other tumor types. None of the sarcoma lines metastasized. Tumors derived from human metastases were no more prone to metastasizing in nude mice than were tumors derived from primary sites. However, deep penetration of the body wall during growth of the tumor transplant was highly correlated with metastasis (p less than 0.001). Such factors as nude mouse health, tumor size and growth rate, and age and sex of the host mouse were not correlated with metastasis. Serial passage in nude mice did not select for a more malignant tumor line, since the incidence of metastasis did not differ at various passage levels. Thus, metastasis of human malignant tumors in nude mice would appear to depend primarily upon the site of tumor growth in the nude mouse, and upon the intrinsic metastasizing capability of the tumor line employed.

Entities:  

Mesh:

Year:  1979        PMID: 544528     DOI: 10.1002/ijc.2910240605

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  40 in total

1.  Oncolytic herpes viral therapy is effective in the treatment of hepatocellular carcinoma cell lines.

Authors:  Tae-Jin Song; David P Eisenberg; Prasad S Adusumilli; Michael Hezel; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2006-04       Impact factor: 3.452

2.  Efficacy of dacarbazine (DTIC) in preventing metastases arising from intraocular melanomas in mice.

Authors:  G E Sanborn; J Y Niederkorn; J W Gamel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice.

Authors:  S Visonneau; A Cesano; M H Torosian; E J Miller; D Santoli
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  Comparative studies between nude and scid mice on the growth and metastatic behavior of xenografted human tumors.

Authors:  X Xie; N Brünner; G Jensen; J Albrectsen; B Gotthardsen; J Rygaard
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

5.  In vivo selection of human renal cell carcinoma cells with high metastatic potential in nude mice.

Authors:  S Naito; S M Walker; I J Fidler
Journal:  Clin Exp Metastasis       Date:  1989 Jul-Aug       Impact factor: 5.150

6.  Prevention of metastasis of intraocular melanoma in mice treated with difluoromethylornithine.

Authors:  G Sanborn; J Niederkorn; J Kan-Mitchell; D Albert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

7.  A metastatic model of human colon cancer constructed using cecal implantation of cancer tissue in nude mice.

Authors:  T Furukawa; T Kubota; M Watanabe; T H Kuo; H Nishibori; S Kase; Y Saikawa; H Tanino; T Teramoto; K Ishibiki
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

8.  Novel experimental models of human cancer metastasis in nude mice: lung metastasis, intraabdominal carcinomatosis with ascites, and liver metastasis.

Authors:  Y Naomoto; H Kondo; N Tanaka; K Orita
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 9.  Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAF.

Authors:  Z A Antonello; C Nucera
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

Review 10.  Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis.

Authors:  I J Fidler
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.